Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Does a positive Anaplasma IgM alone diagnose active anaplasmosis?

A positive Anaplasma IgM result by itself does not establish active anaplasmosis.

UnsupportedSeptember 23, 20264 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

A positive Anaplasma IgM result without compatible clinical illness or confirmatory evidence can be false positive or persistent, so it does not by itself establish active anaplasmosis.

laying out figure…
1 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says isolated Anaplasma IgM can be false positive, cross-reactive, or persistent when there is no compatible acute illness. The mechanism framing emphasizes that diagnosis depends on clinical context plus confirmatory evidence such as PCR or paired IgG testing, rather than IgM alone.

Verified conclusion

In a 77-year-old man, interpretation of an Anaplasma antibody result should be driven by the presence or absence of a compatible acute syndrome and corroborating testing, rather than by IgM alone.

Clinical interpretation

  • A positive Anaplasma IgM is less specific and unreliable for diagnosing recent infection. In the absence of compatible acute illness, its positive predictive value is substantially limited.
  • Cross-reactivity between Anaplasma and Ehrlichia antigens can produce a positive but nondiagnostic serologic result. Other nonspecific or alternative-pathogen antibody reactivity may also account for isolated IgM positivity.
  • Antibody persistence is established most clearly for IgG, which may remain elevated for months and occasionally years after resolved infection. Persistence of isolated IgM is less well documented; false-positive or cross-reactive reactivity is the stronger explanation when the clinical presentation is discordant.

Confirmation and diagnostic timing

  • Detection of A. phagocytophilum DNA by whole-blood PCR/NAAT is confirmatory evidence of active anaplasmosis and is preferred during the first week of illness.
  • Serologic confirmation requires paired IgG indirect fluorescent-antibody specimens, with seroconversion or a fourfold rise in titer between acute and convalescent samples collected 2–10 weeks apart. A single antibody measurement cannot provide this confirmation.
  • PCR sensitivity falls after appropriate antibiotic treatment, so a negative PCR does not exclude disease when clinical suspicion is high; treatment should not be delayed solely while awaiting testing.

Bottom line

  • A positive Anaplasma IgM without a compatible acute illness or PCR/paired-IgG confirmation should not be regarded as proof of active anaplasmosis. It is more appropriately interpreted as a potentially false-positive, cross-reactive, or residual antibody finding, with clinical assessment determining whether further testing or empiric treatment is warranted.

References

  1. Clinical Testing and Diagnosis for Anaplasmosis - CDC — cdc.gov ↗
  2. Anaplasmosis 2024 Case Definition | CDC — ndc.services.cdc.gov ↗
  3. Human Granulocytic Anaplasmosis - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  4. Serological reactivity to Anaplasma phagocytophilum in ... — d-nb.info ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible13 sourcesCan gliotoxin and mycophenolic acid alter immune processes without proving neural autoimmunity?→Plausible5 sourcesDo CASPR2 and GABA receptor antibodies alter synaptic signaling, while intracellular onconeural antibodies mark a paraneoplastic process?→